Samsung's Texas chip plant could begin trial runs in December - The Korea Herald

Samsung's Texas fab entering trial runs in December is not a capacity milestone—it is the moment de-risking stops being a policy slogan and becomes a yield-curve problem. The plant targets 14nm/8nm logic and DRAM; trial production signals ASML and AMAT equipment have cleared on-site validation, yet the binding constraint is not lithography but localized supply chains: Texas industrial water quotas are tightening, a structural limitation Samsung's Pyeongtaek campus never faced. On the compliance front, CHIPS Act subsidies carry a ten-year no-layoff clause, and Texas labor costs push wafer-level spend 15-20% above China's Taiwan fabs. Samsung must recover this margin through HBM4 and advanced-packaging premiums. Strategically, TSMC's Arizona 3nm line reaches volume production in 2025 while Intel's Ohio fab advances in parallel. If Samsung's yield ramp exceeds eighteen months, it forfeits the advanced-node delivery window with NVIDIA and AMD. The 12-to-24-month tail effect: US domestic capacity share climbs from under five percent toward fifteen, global DRAM pricing power shifts from a Samsung-SK Hynix-Micron triopoly toward a geopolitical-premium model, and mid-tier OSAT players capture structural upside from localized demand.